CompletedNCT01339598
Official study titleRemediation of Cognitive Dysfunction in Euthymic Bipolar Disorder Patients Using Transcranial Direct Current Stimulation (tDCS)
This study has finished and is no longer accepting participants.
In SydneyBipolarityDevice studyAges 18–65
- Countries
- Australia
- Sponsor
- The University of New South Wales
CompletedNCT02655978
Official study titleRostral Dorsal Cingulum Bundle Connectivity in Patients With Bipolar Disorder
This study has finished and is no longer accepting participants.
In ClevelandBipolarityObservational studyAges 18+
- Countries
- United States
- Sponsor
- University Hospitals Cleveland Medical Center
WithdrawnNCT01124877
Official study title26 Week Open Label Extension Study Evaluating The Safety And Tolerability Of Flexible Doses Of Oral Ziprasidone In Children And Adolescents With Bipolar I Disorder (Manic Or Mixed)
This study was withdrawn before enrollment.
Location not clearly listedBipolarityMedication studyAges 10–17
- Countries
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
CompletedNCT03158805
Official study titleA Randomized, Placebo-Controlled Study of Liraglutide 3mg Daily (Saxenda®) in Obese or Overweight Patients With Stable Bipolar Disorder
This study has finished and is no longer accepting participants.
In MasonBipolarityMedication studyAges 18–65
- Countries
- United States
- Sponsor
- Lindner Center of HOPE
UnknownNCT06282250
Official study titleAn Explorative and Experimental Study to Assess the Feasibility, Acceptability, and Effectiveness of Early Intervention With Light, Lifestyle and ImCT Therapy in Individuals at Risk for Bipolar Disorder
Current recruitment status is unconfirmed.
In EindhovenBipolarityBehavioural studyAges 16–35
- Countries
- Netherlands
- Sponsor
- Geestelijke Gezondheidszorg Eindhoven (GGzE)
UnknownNCT06271304
Official study titleStabilizing Mood and Sleep With Blue Blocking Eyewear in Bipolar Disorder
Current recruitment status is unconfirmed.
In CopenhagenBipolarityDevice studyAges 18–60
- Countries
- Denmark
- Sponsor
- Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital
CompletedNCT00721955
What is this study about?Researchers compared Inhaled loxapine 5 mg, Inhaled loxapine 10 mg and placebo to find out how the approaches affected psychotic symptoms in people with bipolarity type I.
This study has finished and is no longer accepting participants.
Multiple locations, including EscondidoBipolarityMedication studyAges 18–65
- Countries
- United States
- Sponsor
- Alexza Pharmaceuticals, Inc.
TerminatedNCT00575328
Official study titleA Double-Blind, Placebo Controlled Study of Maca Root for the Treatment of Sexual Dysfunction Associated With the Treatment Regimen for Bipolar Disorder in Females
This study ended early.
In BostonBipolarityMedication studyAges 18–80
- Countries
- United States
- Sponsor
- Massachusetts General Hospital (Hospital / academic medical center)
CompletedNCT00076115
What is this study about?This study evaluated the safety and effectiveness of Risperidone for people with bipolarity.
This study has finished and is no longer accepting participants.
Location not clearly listedBipolarityMedication studyAges 10–17
- Countries
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
CompletedNCT02855762
Official study titleTargeting the Microbiome to Improve Clinical Outcomes in Bipolar Disorder
This study has finished and is no longer accepting participants.
In Ann ArborBipolarityInterventional studyAges 25–65
- Countries
- United States
- Sponsor
- Melvin McInnis, MD
CompletedNCT06113887
Official study titleThe Effect of Acceptance and Commitment Therapy Based Psychoeducation on Psychological Flexibility and Impulsivity Levels in Bipolar Disorder Patients
This study has finished and is no longer accepting participants.
In GaziantepBipolarityInterventional studyAges 18–65
- Countries
- Türkiye
- Sponsor
- University of Gaziantep
CompletedNCT01371383
Official study titleThe Effect of Omega-3 Polyunsaturated Fatty Acids in the Treatment and Prevention of Relapse of Bipolar Disorder.
This study has finished and is no longer accepting participants.
In TaichungBipolarityPlacebo comparisonAges 18–65
- Countries
- Taiwan
- Sponsor
- National Science and Technology Council, Taiwan